• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


3.460 EUR 0.007 0.20%

As of 09:00:37 ET on 01/26/2015.

Snapshot for BioTime Inc (BT3)

Open: 3.369 Day's Range: 3.309 - 3.460 Volume: 6,445
Previous Close: 3.467 52wk Range: 1.621 - 3.907 1-Yr Rtn: +18.70%

Stock Chart for BT3

No chart data available.
  • BT3:GR 3.460
  • 1D
  • 1M
  • 1Y
Interactive BT3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BT3

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 287.60
Shares Outstanding (M) 83.12
30 Day Average Volume 960
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BT3

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BT3

BioTime, Inc. researches and develops synthetic solutions that can be used as blood plasma volume expanders, blood replacement solutions during hypothermic surgery, and organ preservation solutions. The Company also operates in regenerative medicine sector, where it develops stem cell related products and technology for diagnostic, therapeutic and research use.

Michael D WestChief Executive OfficerAditya MohantyChief Operating Officer
Lesley A StolzExec VP:Corporate DevelopmentRobert W PeabodySenior VP/CFO
More Company Profile & Key Executives for BT3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil